Product Code: ETC4471043 | Publication Date: Jul 2023 | Updated Date: Aug 2025 | Product Type: Report | |
Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 85 | No. of Figures: 45 | No. of Tables: 25 |
The Japan Apheresis Market is a rapidly growing sector driven by factors such as an increasing prevalence of chronic diseases, technological advancements in apheresis devices, and a growing demand for blood components for therapeutic purposes. Apheresis procedures are widely used in Japan for the treatment of various conditions, including autoimmune diseases, blood disorders, and organ transplant rejection. The market is characterized by the presence of key players offering a wide range of apheresis products and services. Additionally, the Japanese government`s initiatives to enhance healthcare infrastructure and improve access to advanced medical treatments further contribute to the market`s growth. With a focus on innovation and rising healthcare expenditure, the Japan Apheresis Market is poised for continued expansion in the coming years.
The Japan Apheresis Market is experiencing significant growth due to the increasing prevalence of chronic diseases, rising demand for blood components in transfusion procedures, and advancements in apheresis technology. Key trends include the adoption of automated and continuous flow apheresis systems, increasing use of therapeutic apheresis for various autoimmune disorders, and a growing focus on personalized medicine. Opportunities in the market lie in expanding applications of apheresis in oncology, neurology, and hematology, as well as the development of novel apheresis procedures to address unmet medical needs. Additionally, collaborations between industry players and research institutions to innovate new apheresis technologies and expand market presence are expected to drive market growth in Japan.
In the Japan Apheresis Market, there are several challenges that industry players face. One significant challenge is the high cost associated with apheresis procedures, which can limit access to treatment for some patients due to financial constraints. Additionally, there is a shortage of skilled healthcare professionals trained in performing apheresis procedures, leading to potential delays in patient care. Regulatory hurdles and the need for continuous technological advancements also pose challenges in this market. Furthermore, raising awareness among both healthcare providers and patients about the benefits of apheresis therapy and its applications in various medical conditions is crucial for market growth. Overall, addressing these challenges will be vital for the sustainable growth and development of the Japan Apheresis Market.
The Japan Apheresis Market is primarily driven by factors such as the increasing incidence of blood disorders and autoimmune diseases in the country, leading to a growing demand for apheresis procedures. Technological advancements in apheresis devices and procedures, along with a rising geriatric population that is more prone to various health conditions requiring apheresis treatment, are also significant drivers in the market. Furthermore, the increasing awareness about the benefits of apheresis therapy among healthcare providers and patients, coupled with the expanding healthcare infrastructure and government initiatives to improve blood donation rates, are contributing to the market`s growth in Japan. Overall, these factors are expected to continue driving the Japan Apheresis Market in the coming years.
The Japan government has implemented several policies related to the apheresis market to ensure quality, safety, and accessibility of apheresis procedures. These policies include regulations set by the Pharmaceuticals and Medical Devices Agency (PMDA) to oversee the approval and monitoring of apheresis devices and procedures. Additionally, the government has established reimbursement policies through the national healthcare system to cover apheresis treatments for certain medical conditions. The Ministry of Health, Labour and Welfare (MHLW) also provides guidelines for healthcare facilities to ensure proper training and certification of medical professionals performing apheresis procedures. Overall, these policies aim to promote the effective use of apheresis technology in Japan while safeguarding patient welfare and promoting healthcare quality.
The Japan Apheresis market is expected to witness steady growth in the coming years, driven by factors such as the increasing prevalence of chronic diseases, rising geriatric population, and advancements in apheresis technology. The demand for apheresis procedures for the treatment of various autoimmune disorders, blood disorders, and organ transplant procedures is expected to fuel market growth. Additionally, the growing awareness about the benefits of apheresis therapies, along with government initiatives to improve healthcare infrastructure, will further contribute to market expansion. However, factors such as high treatment costs and a shortage of skilled professionals may pose challenges to market growth. Overall, with the ongoing developments in healthcare technology and increasing healthcare expenditure, the Japan Apheresis market is poised for significant growth in the foreseeable future.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Apheresis Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Apheresis Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Apheresis Market - Industry Life Cycle |
3.4 Japan Apheresis Market - Porter's Five Forces |
3.5 Japan Apheresis Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Japan Apheresis Market Revenues & Volume Share, By Method, 2021 & 2031F |
3.7 Japan Apheresis Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
3.8 Japan Apheresis Market Revenues & Volume Share, By Component, 2021 & 2031F |
3.9 Japan Apheresis Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Japan Apheresis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Japan |
4.2.2 Technological advancements in apheresis devices |
4.2.3 Growing adoption of apheresis procedures in therapeutic applications |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for apheresis products in Japan |
4.3.2 High cost associated with apheresis procedures |
4.3.3 Limited awareness about apheresis therapy among healthcare professionals and patients |
5 Japan Apheresis Market Trends |
6 Japan Apheresis Market, By Types |
6.1 Japan Apheresis Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Japan Apheresis Market Revenues & Volume, By Product, 2021 - 2031F |
6.1.3 Japan Apheresis Market Revenues & Volume, By Devices, 2021 - 2031F |
6.1.4 Japan Apheresis Market Revenues & Volume, By Disposable and Reagents, 2021 - 2031F |
6.1.5 Japan Apheresis Market Revenues & Volume, By Software, 2021 - 2031F |
6.2 Japan Apheresis Market, By Method |
6.2.1 Overview and Analysis |
6.2.2 Japan Apheresis Market Revenues & Volume, By Centrifugation, 2021 - 2031F |
6.2.3 Japan Apheresis Market Revenues & Volume, By Membrane Separation, 2021 - 2031F |
6.2.4 Japan Apheresis Market Revenues & Volume, By Selective Adsorption, 2021 - 2031F |
6.3 Japan Apheresis Market, By Procedure |
6.3.1 Overview and Analysis |
6.3.2 Japan Apheresis Market Revenues & Volume, By Donor/Automated Apheresis, 2021 - 2031F |
6.3.3 Japan Apheresis Market Revenues & Volume, By Therapeutic Apheresis, 2021 - 2031F |
6.4 Japan Apheresis Market, By Component |
6.4.1 Overview and Analysis |
6.4.2 Japan Apheresis Market Revenues & Volume, By Plasma (Plasmapheresis), 2021 - 2031F |
6.4.3 Japan Apheresis Market Revenues & Volume, By Platelets (Plateletpheresis), 2021 - 2031F |
6.4.4 Japan Apheresis Market Revenues & Volume, By Leukocytes (Leukapheresis or leukopheresis), 2021 - 2031F |
6.4.5 Japan Apheresis Market Revenues & Volume, By Lymphocytes (Lymphopheresis or lymphapheresis), 2021 - 2031F |
6.4.6 Japan Apheresis Market Revenues & Volume, By RBC's (Erythropheresis), 2021 - 2031F |
6.5 Japan Apheresis Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Japan Apheresis Market Revenues & Volume, By Blood Centers, 2021 - 2031F |
6.5.3 Japan Apheresis Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.5.4 Japan Apheresis Market Revenues & Volume, By Other End Users, 2021 - 2031F |
7 Japan Apheresis Market Import-Export Trade Statistics |
7.1 Japan Apheresis Market Export to Major Countries |
7.2 Japan Apheresis Market Imports from Major Countries |
8 Japan Apheresis Market Key Performance Indicators |
8.1 Average number of apheresis procedures performed per year in Japan |
8.2 Adoption rate of newer apheresis technologies in the market |
8.3 Percentage of healthcare facilities offering apheresis services |
8.4 Patient satisfaction rates post-apheresis treatments |
8.5 Rate of reimbursement for apheresis procedures by insurance providers |
9 Japan Apheresis Market - Opportunity Assessment |
9.1 Japan Apheresis Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Japan Apheresis Market Opportunity Assessment, By Method, 2021 & 2031F |
9.3 Japan Apheresis Market Opportunity Assessment, By Procedure, 2021 & 2031F |
9.4 Japan Apheresis Market Opportunity Assessment, By Component, 2021 & 2031F |
9.5 Japan Apheresis Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Japan Apheresis Market - Competitive Landscape |
10.1 Japan Apheresis Market Revenue Share, By Companies, 2024 |
10.2 Japan Apheresis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |